pharmaphorum September 28, 2022
Kyle Faget

In Part 1 of this series, general wellness devices and mobile medical applications (MMAs) will be considered. Part 2 of this series will be devoted to clinical decision support (CDS) software.

The FDA’s General Approach to Regulating mHealth Products

Although mHealth has been gaining in popularity for at least the past decade, before commercializing their mHealth products, developers must determine whether the product is subject to U.S. Food and Drug Administration (FDA) regulation as a medical device. If so, developers must develop and execute on a regulatory strategy.

Determining whether a product is a medical device subject to FDA regulation necessarily begins with understanding the FDA regulatory definition of ‘medical device’. A medical device is statutorily defined as an instrument,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, mHealth, Technology
Apple’s latest AI research could completely transform your iPhone
New AI model aims to fix flaws in smartphone-based COVID-19 X-ray diagnosis
Apple can now assess your risk for depression, anxiety
Samsung, b.well partner to collect health data on Galaxy smartphones
Samsung, b.well partner to provide longitudinal data to Galaxy smartphone users

Share This Article